These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34844820)

  • 1. International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety.
    Robertson JS; Loizides U; Adisa A; López de la Rica Manjavacas A; Rodilla V; Strnadova C; Weisser K; Balocco R
    Vaccine; 2022 Jan; 40(1):21-27. PubMed ID: 34844820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough.
    Loizides U; Dominici M; Manderson T; Rizzi M; Robertson JS; de Sousa Guimarães Koch S; Timón M; Balocco R
    Cytotherapy; 2021 May; 23(5):357-366. PubMed ID: 33820700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International nonproprietary names for monoclonal antibodies: an evolving nomenclature system.
    Guimaraes Koch SS; Thorpe R; Kawasaki N; Lefranc MP; Malan S; Martin ACR; Mignot G; Plückthun A; Rizzi M; Shubat S; Weisser K; Balocco R
    MAbs; 2022; 14(1):2075078. PubMed ID: 35584276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The INN global nomenclature of biological medicines: A continuous challenge.
    Robertson JS; Chui WK; Genazzani AA; Malan SF; López de la Rica Manjavacas A; Mignot G; Thorpe R; Balocco R; Rizzi M
    Biologicals; 2019 Jul; 60():15-23. PubMed ID: 31130314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Identical INN "Imiglucerase" for Different Drug Products: Impact Analysis of Adverse Events in a Proprietary Global Safety Database.
    Tsang SF; Pandya S; Barakov K; Keutzer J; Lewis G; Ross L; Freisens S
    Drug Saf; 2022 Feb; 45(2):127-136. PubMed ID: 35020177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 vaccine candidates in rapid development.
    Li L; Guo P; Zhang X; Yu Z; Zhang W; Sun H
    Hum Vaccin Immunother; 2021 Mar; 17(3):644-653. PubMed ID: 33121319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 2020 race towards SARS-CoV-2 specific vaccines.
    Karpiński TM; Ożarowski M; Seremak-Mrozikiewicz A; Wolski H; Wlodkowic D
    Theranostics; 2021; 11(4):1690-1702. PubMed ID: 33408775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of vaccine development for COVID-19.
    Shahcheraghi SH; Ayatollahi J; Aljabali AA; Shastri MD; Shukla SD; Chellappan DK; Jha NK; Anand K; Katari NK; Mehta M; Satija S; Dureja H; Mishra V; Almutary AG; Alnuqaydan AM; Charbe N; Prasher P; Gupta G; Dua K; Lotfi M; Bakshi HA; Tambuwala MM
    Ther Deliv; 2021 Mar; 12(3):235-244. PubMed ID: 33624533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The COVID-19 pandemic: viral variants and vaccine efficacy.
    Ciotti M; Ciccozzi M; Pieri M; Bernardini S
    Crit Rev Clin Lab Sci; 2022 Jan; 59(1):66-75. PubMed ID: 34598660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International Nonproprietary Names (INN) for pharmaceutical substances.
    Kopp-Kubel S
    Bull World Health Organ; 1995; 73(3):275-9. PubMed ID: 7614659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.
    Lambert PH; Ambrosino DM; Andersen SR; Baric RS; Black SB; Chen RT; Dekker CL; Didierlaurent AM; Graham BS; Martin SD; Molrine DC; Perlman S; Picard-Fraser PA; Pollard AJ; Qin C; Subbarao K; Cramer JP
    Vaccine; 2020 Jun; 38(31):4783-4791. PubMed ID: 32507409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 vaccine trials: The use of active controls and non-inferiority studies.
    Fleming TR; Krause PR; Nason M; Longini IM; Henao-Restrepo AM
    Clin Trials; 2021 Jun; 18(3):335-342. PubMed ID: 33535811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series.
    Assawasaksakul T; Sathitratanacheewin S; Vichaiwattana P; Wanlapakorn N; Poovorawan Y; Kittanamongkolchai W
    RMD Open; 2021 Dec; 7(3):. PubMed ID: 34862313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frontrunners in the race to develop a SARS-CoV-2 vaccine.
    Russell RL; Pelka P; Mark BL
    Can J Microbiol; 2021 Mar; 67(3):189-212. PubMed ID: 33264067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19: Coronavirus Vaccine Development Updates.
    Zhao J; Zhao S; Ou J; Zhang J; Lan W; Guan W; Wu X; Yan Y; Zhao W; Wu J; Chodosh J; Zhang Q
    Front Immunol; 2020; 11():602256. PubMed ID: 33424848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SARS-CoV-2 vaccines].
    Benfield TL; Helweg-Larsen J
    Ugeskr Laeger; 2021 Mar; 183(10):. PubMed ID: 33734065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.